The Rett Syndrome market is on an impressive upward trajectory, anticipating a significant increase in its valuation from USD 0.33 million in 2024 to an estimated USD 1.368 million by 2035. This represents a compound annual growth rate (CAGR) of 13.80%, highlighting robust investment and research in this rare disorder. The growth is fueled by advancements in genetic research and the...